Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Verified Clinical Trials and ClinSpark® Now To Offer Single Access Point For eSource and Research Subject Verification To Prevent Duplicate Subjects in Clinical Trials

The global research subject duplicate enrollment prevention solution Verified Clinical Trials (VCT) and Foundry Health's eSource and phase I automation platform ClinSpark are now electronically connected. The integration greatly simplifies the process for site users to check for duplicate subject enrollments and several other protocol violations.


News provided by

Verified Clinical Trials

Jan 23, 2019, 03:00 ET

Share this article

Share toX

Share this article

Share toX

Verified Clinical Trials (VCT) and Foundry Health’s eSource and phase I automation platform ClinSpark® are electronically connected.
Verified Clinical Trials (VCT) and Foundry Health’s eSource and phase I automation platform ClinSpark® are electronically connected.

GARDEN CITY, N.Y., Jan. 23, 2019 /PRNewswire-PRWeb/ -- The global research subject duplicate enrollment prevention solution Verified Clinical Trials (VCT) and Foundry Health's eSource and phase I automation platform ClinSpark® are now electronically connected. The integration greatly simplifies the process for site users to check for duplicate subject enrollments and several other protocol violations. All relevant data is automatically synced, eliminating double entry of data and thereby reducing errors and diminishing workload. An eligibility check with the Verified Clinical Trials database is initiated from within the site's ClinSpark® interface. With just one button to press, the powerful technology of VCT is activated and the user instantly receives a response on the verification check within seconds. A full report with relevant details is automatically added to the source data in ClinSpark® and is accessible to all authorized study users.

Duplicate or over enrollment is a well-recognized and growing problem within the clinical trials industry. VCT and Foundry Health both strongly believe that technology can greatly enhance the safety of subjects in clinical trials and improve the quality of the data. VCT and Foundry Health now offer a simplified and more expedient process by developing a single combined access point for data entry and research subject enrollment status verification. Due to the web-based nature of each solution, a clear path towards collaboration between the technology providers emerged in a way that has not been seen with traditional on-premise solution providers. The results of this joint effort lead to enhanced compliance, a reduction in error rates, and improved efficiency. The one-click verification of research subject enrollment status step is a first step in this collaboration between the two companies.

VCT and Foundry Health now offer a simplified and more expedient process by developing a single combined access point for data entry and research subject enrollment status verification.

Post this

Mitchell Efros MD FACS, CEO of VCT stated, "Volunteer safety is paramount in everything we do. Developing new technology as a means to achieve that is at the heart of our company. We are very pleased to see that ClinSpark® is built on those same values. This collaboration will enrich the clinical trial landscape as we know it today. We are very pleased with our alliance and it was great seeing the teams working so closely together to develop such a powerful yet efficient tool. We look forward to further enhancements as we continue our collaboration."

Brock Heinz, CEO of Foundry Health stated "The modern architecture of ClinSpark® empowers us to easily connect to anything: devices, databases, or other cloud-based solutions. Verified Clinical Trials is without question the world leader in solutions for preventing duplicate enrollment of subjects in trials. It has been a privilege to collaborate with them and have our systems and teams working closely together. ClinSpark® is focused on making it simple and easy to run a phase I trial for the clinic staff. Our interface with VCT is yet another step in achieving that goal."

Kerri Weingard ANP COO of http://www.verifiedclinicaltrials.com added, "We strive to provide solutions to our clients that enhance the safety and quality of data yet do not over-burden research site staff. With increasingly complex clinical trials and a myriad of systems for site staff to log in to, we felt that a single access point to perform these functions would enhance the user experience and acceptance for both systems.

About Verified Clinical Trials
Verified Clinical Trials is a forward-thinking company developed by experts active in the clinical research community to improve research subject safety and data quality in clinical research trials by preventing duplicate enrollment and other protocol violations. Verified Clinical Trials defines itself as the world's leader in the field of database registries in clinical trial research. Verified Clinical Trials is the only clinical research database registry designed specifically to enhance the quality of both early and late phase trials and has the scalability to reach all sites nationally as well as on a global level. Verified Clinical Trials offers optional fingerprint biometric verification to improve accuracy and speed. For more information, visit http://www.verifiedclinicaltrials.com.

About Foundry Health
Foundry Health is the company behind ClinSpark®, the modern cloud-based Phase I automation and eSource platform. Its modern infrastructure allows for easy connection to clinical devices, labs, databases and data review tools of all sorts. The solid (CDISC ODM certified) data structure ensures compliance with all regulatory and data standards. The modern 'mobile-first' user interface and fast bar-code enhanced navigation, make the system easy to use and contribute to the highest user experience ratings in the industry. ClinSpark® is offered as a SaaS (Software as a Service) solution with no long-term commitments, and a competitive 'pay-per-use' pricing structure. Being hosted on one of the world's most advanced cloud-infrastructures, ClinSpark® allows for almost infinite global scaling without performance degradation. For more information, visit http://www.foundryhealth.com/.

SOURCE Verified Clinical Trials

Related Links

http://www.verifiedclinicaltrials.com

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.